This is how the market solves problems. The freer the market the quicker problems get solved generally.
It shouldn’t have taken this long.
(From The USAToday)
CVS Health Thursday that it would start selling the generic version of a competitor to pharmaceutical giant Mylan’s EpiPen, an injection for people having severe allergy reactions. The move comes amid public consternation over multiple price increases that left the brand-name allergic-reaction treatment EpiPen with a list price of more than $600, up from about $100 in 2009.
CVS says the generic based off Impax Laboratories’ Adrenaclick treatment will sell for $109.99 per two-pack before potential discounts, or about one-third the initial $300 list price of the generic version of the EpiPen that Mylan announced after criticism about pricing.